June 8, 2026 - 04:46

Solidion Technology Inc. saw its stock price skyrocket by more than 668 percent this week following the announcement of a new graphene-based battery platform designed for extreme space environments. The company revealed patented breakthroughs in lithium metal and extreme-climate battery systems tailored for satellites, Low Earth Orbit AI data centers, crewed spacecraft, and future lunar infrastructure.
The company holds over 385 patents related to its battery technology. A key focus of the announcement was Solidion's graphene-enabled, ultra-wide-temperature batteries, which are built to withstand the harsh thermal swings of space. The company also highlighted its domestic graphite production capabilities, aiming to reduce reliance on foreign supply chains.
Analysts noted that the market reacted strongly to the potential applications in the growing space economy, particularly for AI data centers in orbit and long-duration lunar missions. The technology addresses two major challenges in spaceflight: extreme temperature fluctuations that can degrade standard batteries, and the need for reliable power sources for extended operations beyond Earth.
Solidion's stock has been highly volatile since the news broke, with trading volume spiking dramatically. While the long-term commercial viability of the platform remains to be seen, the initial investor enthusiasm reflects growing interest in advanced energy storage solutions for the aerospace sector.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...